Temazepam

替马西泮

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTemazepam
Drug Alias NameTemazepamum羟基安定NormisonRemestanRestoril +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsSleep Initiation and Maintenance Disorders
Global Approved IndicationsSleep Initiation and Maintenance Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date1969/01/01
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMallinckrodt
China Registration ClassN/A

Develop Information

Active CompaniesSpecgx LlcMallinckrodt
Inactive CompaniesN/A
Active IndicationsSleep Initiation and Maintenance Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN05CD07
Related LinksWikipediaDrugBankKEGG